Last updated on September 2018

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies


Brief description of study

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.

Clinical Study Identifier: NCT03538028

Contact Investigators or Research Sites near you

Start Over

Incyte Corporation Call Center (US)

The Angeles Clinic and Research Center
Los Angeles, CA United States
  Connect »

Incyte Corporation Call Center (US)

Hackensack Medical Center
Hackensack, NJ United States
  Connect »

Incyte Corporation Call Center (US)

Carolina BioOncology Institute
Huntersville, NC United States
  Connect »

Incyte Corporation Call Center (US)

Vanderbilt University Medical Center
Nashville, TN United States
  Connect »